Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitorsMichael Dougan, Ada G Blidner, Jennifer Choi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Cancer immunotherapy-related adverse events: causes and challengesAda G Blidner, Jennifer Choi, Tim Cooksley, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 4, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicityVickie R Shannon, Ronald Anderson, Ada Blidner, et al.
The American Journal of Medicine|August 12, 2019
Routine Microbiologic Studies of Pleural Fluid Specimens in Cancer PatientsMarshall Bailey, Georgie Eapen, David Ost, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe dermatological toxicities from checkpoint inhibitorsJennifer Choi, Ronald Anderson, Ada Blidner, et al.
Journal of Bronchology & Interventional Pulmonology|April 12, 2019
Incidence of Bleeding Complications With Flexible Bronchoscopy in Cancer Patients With ThrombocytopeniaSaadia A Faiz, Carlos A Jimenez, Bryan M Fellman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 29, 2020
Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-mediated cardiovascular, rheumatic, and renal toxicities from checkpoint inhibitorsMaria E Suarez-Almazor, Xerxes Pundole, Noha Abdel-Wahab, et al.
The Journal of Infectious Diseases|November 20, 2023
Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With CancerAlexander Franklin, Teny M John, Fareed Khawaja, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 13, 2025
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Relapsed or Refractory LymphomaFelipe Soto, Ugochi Ebinama, William P Brasher, et al.
Pageof 4